MDLN
Medline Inc-cl A
5 of the 83 super-investors we track hold MDLN, worth a combined $1.77B per their latest 13F filings. The largest position: John Armitage at 6.3% of their portfolio. This quarter the cohort logged 2 buys and 1 sell on the name. Conviction score: 24 of 100 (how strongly the cohort backs it) — ranked #568 of 742 stocks. Conviction easing: 1 fewer super-investor hold it than in 2026Q1.
Why super-investors own MDLN
MDLN is held by 5 super-investors in our cohort, with a combined position value of $1.8B. The highest-conviction owner is John Armitage at 6.3% of their portfolio. This quarter the cohort registered 2 added, 1 trimmed.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2025Q4 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (5) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Stephen Mandel | 5.1% | 3q | $827M | 20,968,367 |
| 2 | John Armitage | 6.3% | 2q | $650M | 16,470,884 |
| 3 | Viking Global Investors | 0.5% | 3q | $191M | 4,841,080 |
| 4 | Henry Ellenbogen | 1.0% | 3q | $104M | 2,627,321 |
| 5 | Joel Greenblatt | <0.1% | 3q | $1M | 32,586 |
Owners of MDLN also hold
Recent activity (3)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Henry Ellenbogen | TRIM | 1.0% | -64% | $104M | Aug 14, 2026 |
| Stephen Mandel | ADD | 5.1% | +78% | $827M | Aug 14, 2026 |
| John Armitage | ADD | 6.3% | +277% | $650M | Jul 21, 2026 |
Long US equity 13F-HR filings only. CUSIP 58507V107. Not investment advice.